MDASI Head and Neck Cancer Module
The MD Anderson Symptom Inventory for head and neck cancer (MDASI-HN) is a site-specific MDASI module. Along with the core MDASI’s 13 symptom items and 6 interference items, the MDASI-HN also assesses 9 symptoms relevant to head and neck cancer:
- mucus in the mouth and throat
- difficulty swallowing or chewing
- choking or coughing
- difficulty with voice or speech
- skin pain/burning/rash
- constipation
- problems with tasting food
- mouth/throat sores
- problems with teeth or gums
Order the MDASI Head and Neck Module
Use our convenient online form to order the MDASI-HN for use in your clinical research, clinical practice, funded and non-funded academic research, commercial research, or reproduction in educational materials or other publications.
Every MDASI Module Contains...
All 13 MDASI core symptoms
pain, fatigue, nausea, disturbed sleep, distress, shortness of breath, difficulty remembering, lack of appetite, drowsiness, dry mouth, sadness, vomiting, numbness/tingling
All 6 MDASI interference items
general activity, mood, work, relations with others, walking, enjoyment of life
MDASI-HN Features
- Purpose: To assess the severity of multiple head and neck cancer-related symptoms and the impact of these symptoms on daily functioning
- Population: Patients with symptoms caused by head and neck cancer and its treatment
- Assessment areas: Severity of multiple symptoms and the impact of symptoms on daily functioning during the last 24 hours
- Method: Self-report; paper-and-pencil form or tablet PC (self-administered or via interview), or telephone-based interactive voice response (IVR) system
- Time required: Five minutes
- Scoring: Please see the MDASI User's Guide
- Reliability: Cronbach alpha reliability ranges from 0.72 to 0.92
MDASI-HN Language Versions
Click on a linked language to view a sample in PDF format.
Don't see a language you need? Contact us at symptomresearch@mdanderson.org.
| Psychometrically and Linguistically Validated | Linguistically Validated |
|---|---|
| English | Chinese (Simplified) |
Selected MDASI-HN References
Validation
Rosenthal DI, Mendoza TR, Chambers MS, et al. Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson Symptom Inventory, head and neck module. Head Neck 29(10): 923-931, 2007.
Gunn GB, Koukourakis MI, Mendoza TR, Cleeland CS, Rosenthal DI. Linguistic validation of the Greek M. D. Anderson Symptom Inventory -- Head and Neck Module. Forum of Clinical Oncology 3(1): 17-19, 2012.
Cleeland CS, Mendoza TR, Wang XS, et al. Assessing Symptom Distress in Cancer: The M. D. Anderson Symptom Inventory. Cancer 89:1634-1646, 2000.
Clinical Application
Rosenthal DI, Mendoza TR, Chambers MS, et al. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys 72(5): 1355-1361, 2008.
Gunn GB, Chronowski GM, Garden AS, Frank SJ, Morrison WH, Beadle BM, Lewis CM, Mendoza TR, Cleeland CS, Rosenthal DI. Symptom-free cure following unilateral radiation therapy for tonsil cancer: a PRO benchmark [abstract]. American Society for Radiation Oncology 54th Annual Meeting, Boston MA, Oct 28-31, 2012, 2012; 2012-A-511-ASTRO.
Rosenthal DI, Gunn GB, Garden AS, et al. Pattern of symptoms in head and neck cancer (HNC) survivors treated with radiation therapy (RT): association with systemic therapy [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(Suppl 1), 2012; 5589.
Gunn GB, Fuller CD, Garden AS, Frank SJ, Morrison WH, Beadle BM, Phan J, Mendoza TR, Hanna EY, Ang KK, Cleeland CS, Rosenthal DI. Patient-reported symptoms following IMRT alone for oropharynx cancer: A survivorship study [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(Suppl 1), 2012; 5561.
Rosenthal DI, Gunn GB, Mendoza TR, et al. Long-term symptom burden after radiation treatment for oropharynx cancer: A comparison of 3D and IMRT techniques [abstract]. American Society of Clinical Oncology 47th Annual Meeting, Chicago IL, Jun 3-7, 2011. J Clin Oncol 29(15 Suppl), 2011; 5539.
Gunn GB, Mendoza TR, Garden AS, et al. Patient-reported fatigue in head and neck cancer survivors [abstract]. American Society of Clinical Oncology 47th Annual Meeting, Chicago IL, Jun 3-7, 2011. J Clin Oncol 29(15 Suppl), 2011; 5523.
Rosenthal DI, Mendoza TR, Gunn GB, et al. The persistence of symptom burden after radiation treatment for head and neck cancer [abstract]. American Society of Clinical Oncology 2010 Annual Meeting, Chicago IL, Jun 4-8, 2010. J Clin Oncol 28(15 Suppl): 439s, 2010; 5573.
Gunn GB, Mendoza TR, Wang XS, et al. The relationship of presenting symptom burden and survival in patients with head and neck cancer (HNC) [abstract]. American Society of Clinical Oncology 2010 Annual Meeting, Chicago IL, Jun 4-8, 2010. J Clin Oncol 28(15 Suppl): 446s, 2010; 5600.
Badr H, Rosenthal DI, Milbury K, et al. Do the treatment outcome priorities of head and neck cancer patients change after undergoing radiation treatment? [abstract]. American Society of Clinical Oncology 2010 Annual Meeting, Chicago IL, Jun 4-8, 2010. J Clin Oncol28(15 Suppl): 445s, 2010; 5599.
Rosenthal DI, Mendoza T, Cleeland C. Identifying head and neck patients at risk for high symptom burden during treatment [abstract]. American Society of Clinical Oncology 2009 Annual Meeting, Orlando FL, May 29 - Jun 2, 2009. J Clin Oncol27(15 Suppl), 2009; 6066.
Methodology
Mendoza TR, Gunn GB, Fuller CD, Wang XS, Rosenthal DI, Cleeland CS. The utility of using area under the curve to analyze symptom burden during radiation/chemoradiation for head & neck cancer [abstract]. American Society of Clinical Oncology 47th Annual Meeting, Chicago IL, Jun 3-7, 2011. J Clin Oncol29(15 Suppl), 6/2011; 5525.
Shi Q, Rosenthal DI, Mendoza T, Cleeland CS. Using group-based trajectory modeling to examine heterogeneity of cancer-related symptoms [abstract]. International Society for Quality of Life Research 17th Annual Conference, London, England, Oct 27-30, 2010. Qual Life Res 19(Suppl 1): 51, 2010; 1393.
Mendoza T, Rosenthal D, Wang X, Mobley G, Cleeland C. Measuring the symptom burden of head and neck cancer patients undergoing concurrent chemotherapy and radiation therapy using area under the curve [abstract]. American Society of Clinical Oncology 2009 Annual Meeting, Orlando FL, May 29 - Jun 2, 2009. J Clin Oncol 27(15 Suppl), 5/2009; 6067.